Expression of multidrug-resistance P-glycoprotein (MDR1) in human brain tumors: P-GP in Brain Tumors

International Journal of Cancer

Volumn 93, Issue 1, 2001, Pages 62-66

  Demeule, Michel ^a   Shedid, Daniel ^b   Beaulieu, Édith ^a   Del Maestro, Rolando F ^c   Moghrabi, Albert ^d   Ghosn, Pierre B ^e   Moumdjian, Robert ^b   Berthelet, France ^b   Béliveau, Richard ^a,b  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

^e UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Brain tumor; MDR1; Metastasis; Multidrug resistance; P glycoprotein

Indexed keywords

GLYCOPROTEIN P;

ADENOCARCINOMA; ARTICLE; BLOOD BRAIN BARRIER; BRAIN METASTASIS; BRAIN TUMOR; CANCER GRADING; CAPILLARY WALL; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR BLOOD FLOW;

ASTROCYTOMA; BRAIN CHEMISTRY; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; LUNG NEOPLASMS; MELANOMA; MENINGIOMA; NEURILEMMOMA; OLIGODENDROGLIOMA; P-GLYCOPROTEIN; REFERENCE VALUES;

EID: 0035399586     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1306     Document Type: Article

References (39)

1. The chemotherapy of high-grade astrocytomas
2. Contemporary approaches of chemotherapy
3. Chemotherapy and chemosensitization
4. Biochemistry of multidrug resistance mediated by the multidrug transporter
5. P-glycoprotein: Its role in drug resistance
6. Structure of the multidrug resistance P-glycoprotein
7. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein
8. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues
9. P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain
10. P-glycoprotein, a gatekeeper in the blood-brain barrier
11. Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells: Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes
12. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities
13. The inability of the mouse mdr2 gene to confer multidrug resistance is linked to reduced drug binding to the protein
14. (mdr3) is the major form of P-glycoprotein expressed in mouse brain capillaries. Evidence for cross-reactivity of antibody C219 with an unrelated protein
15. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
16. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
17. P-glycoprotein-mediated efflux transport of anticancer drugs at the blood-brain barrier
18. The blood-brain barrier efflux transporters as a detoxifying system for the brain
19. Visualization of multidrug resistance in vivo
20. The blood-brain barrier and oncology: New insights into function and modulation
21. P-glycoprotein expression in brain tumors
22. MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors
23. Expression of the multidrug-resistance P-glycoprotein (Pgp, MDR-1) by endothelial cells of the neovasculature in central nervous system tumors
24. P-glycoprotein of blood-brain barrier: Cross-reactivity of Mab C219 with a 190 kDa protein in bovine and rat isolated brain capillaries
25. BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123
26. Brain metastases
27. Multidrug resistant malignant melanoma with intracranial metastasis responding to immunotherapy
28. Multidrug resistance in glioblastoma. Chemosensitivity testing and immunohistochemical demonstration of P-glycoprotein
29. The multidrug-resistance gene MDR1 is expressed in human glial tumors
30. Multidrug resistance gene (MDR1) expression in human brain tumors
31. Spontaneous multidrug transport in human glioma cells is regulated by transforming growth factors type beta
32. Comparative assessment of P-glycoprotein expression in tissues by immunoblotting
33. Meningiomas
34. Extra-axial brain tumors
35. Calpain-dependent proteolysis of NF2 protein: Involvement in schwannomas and meningiomas
36. Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningiomas: A correlative immunohistochemical study of 175 cases
37. p53 and PCNA expression in benign, atypical and malignant meningiomas
38. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo
39. Transporting therapeutics across the blood-brain barrier